Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Selective serotonin-reuptake inhibitors: an update.

Masand PS, Gupta S.

Harv Rev Psychiatry. 1999 Jul-Aug;7(2):69-84. Review.

PMID:
10471245
2.
3.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
4.

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Figgitt DP, McClellan KJ.

Drugs. 2000 Oct;60(4):925-54. Review.

PMID:
11085201
5.

Potential indications for the selective serotonin reuptake inhibitors.

Boyer WF.

Int Clin Psychopharmacol. 1992 Jun;6 Suppl 5:5-12. Review.

PMID:
1431022
6.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
7.

[Selective serotonin reuptake inhibitor(SSRI)].

Motohashi N.

Nihon Rinsho. 2001 Aug;59(8):1519-22. Review. Japanese.

PMID:
11519151
8.

[Fluoxetine: an update of its use in major depressive disorder in adults].

Gourion D, Perrin E, Quintin P.

Encephale. 2004 Jul-Aug;30(4):392-9. Review. French.

PMID:
15597466
9.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
10.

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

Zohar J, Westenberg HG.

Acta Psychiatr Scand Suppl. 2000;403:39-49. Review.

PMID:
11019934
11.

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Vaswani M, Linda FK, Ramesh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102. Review.

PMID:
12551730
12.
13.

New indications for antidepressants.

Schatzberg AF.

J Clin Psychiatry. 2000;61 Suppl 11:9-17. Review.

14.

Paroxetine: an update of its use in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

Drugs. 2002;62(4):655-703. Review. Erratum in: Drugs 2002;62(10):1461.

PMID:
11893234
15.

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.

Gorman JM, Kent JM.

J Clin Psychiatry. 1999;60 Suppl 4:33-8; discussion 39. Review.

16.

Paroxetine: current status in psychiatry.

Pae CU, Patkar AA.

Expert Rev Neurother. 2007 Feb;7(2):107-20. Review. Erratum in: Expert Rev Neurother. 2007 Mar;7(3):313-4.

PMID:
17286545
17.

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

Bourin M.

Hum Psychopharmacol. 2003 Apr;18(3):185-90. Review.

PMID:
12672169
18.

Citalopram in the treatment of depression and other potential uses in psychiatry.

Tan JY, Levin GM.

Pharmacotherapy. 1999 Jun;19(6):675-89. Review.

PMID:
10391413
19.

Use of serotonin selective reuptake inhibitors in geriatric depression.

Newhouse PA.

J Clin Psychiatry. 1996;57 Suppl 5:12-22. Review.

PMID:
8647788
20.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306

Supplemental Content

Support Center